Get the app
public
ios_share
CFO THOUGHT LEADER
chevron_right
335: Garnering Investor Recognition | Josh Blacher, CFO of Therapix Biosciences
Oct 18, 2017
29:50
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
A brief summary of this episode
CFO THOUGHT LEADER CFO THOUGHT LEADER CFO THOUGHT LEADER